Literature DB >> 3004939

Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes.

P D Fahrlander, M Piechaczyk, K B Marcu.   

Abstract

To assess possible alterations of c-myc transcriptional control in murine B-cell tumors, we have investigated the pattern of DNaseI hypersensitive sites in the gene's putative regulatory region and within the gene in a variety of genomic contexts. A number of such sites were found in several cell types, but none of these was detectable in a gene which was shown to be transcriptionally silent by the criterion of elongation of nascent transcripts in isolated nuclei. These results differ from those of a previous study, in which a DNaseI-hypersensitive site approximately 2 kb upstream of the gene was proposed to be associated with negative regulation of c-myc transcription in human cells. An analysis of DNA sequences presented here reveals that this region is highly homologous between mouse and human, suggesting that these upstream hypersensitive sites do not reflect species-specific regulatory elements. We also present data indicating that this hypersensitive site distinguishes the c-myc alleles in translocation-positive plasma cell tumors which lack c-myc rearrangement. Furthermore, we report the existence of hypersensitive sites within the gene. One of these appears to be associated with cryptic promoters that are employed only when the normal promoters are lost as a consequence of chromosome translocation. These results are discussed in the context of c-myc translocation and gene breakage and with respect to possible stage-specific regulation of the gene's transcriptional competence.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004939      PMCID: PMC554642          DOI: 10.1002/j.1460-2075.1985.tb04065.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

Review 1.  Evolution of tumours and the impact of molecular oncology.

Authors:  G Klein; E Klein
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

2.  Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma.

Authors:  P D Fahrlander; J Sümegi; J Q Yang; F Wiener; K B Marcu; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma.

Authors:  L M Corcoran; S Cory; J M Adams
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

4.  Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element.

Authors:  K S Zaret; K R Yamamoto
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

5.  Viral integration near c-myc in 10-20% of mcf 247-induced AKR lymphomas.

Authors:  Y Li; C A Holland; J W Hartley; N Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cells.

Authors:  M Schwab; G Ramsay; K Alitalo; H E Varmus; J M Bishop; T Martinsson; G Levan; A Levan
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

7.  Microinjected c-myc as a competence factor.

Authors:  L Kaczmarek; J K Hyland; R Watt; M Rosenberg; R Baserga
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

8.  A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin.

Authors:  B J Bonven; E Gocke; O Westergaard
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

9.  Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues.

Authors:  M Piechaczyk; J M Blanchard; L Marty; C Dani; F Panabieres; S El Sabouty; P Fort; P Jeanteur
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

10.  Chromatin structure around the c-myc gene in Burkitt lymphomas with upstream and downstream translocation points.

Authors:  P J Dyson; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

View more
  21 in total

1.  Transcriptional down-regulation of N-myc expression during B-cell development.

Authors:  R K Smith; K Zimmerman; G D Yancopoulos; A Ma; F W Alt
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity.

Authors:  N L DiFronzo; C A Holland
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

3.  Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II.

Authors:  T Albert; J Mautner; J O Funk; K Hörtnagel; A Pullner; D Eick
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter.

Authors:  E Kakkis; M Mercola; K Calame
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

5.  Deregulation of the c-myc oncogene in virus-induced thymic lymphomas of AKR/J mice.

Authors:  A Reicin; J Q Yang; K B Marcu; E Fleissner; C F Koehne; P V O'Donnell
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  Rapid and reversible changes in nucleosome structure accompany the activation, repression, and superinduction of murine fibroblast protooncogenes c-fos and c-myc.

Authors:  T A Chen; V G Allfrey
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  A plasmacytoma-specific factor binds the c-myc promoter region.

Authors:  E Kakkis; K Calame
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei.

Authors:  I I Gromova; B Thomsen; S V Razin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

9.  Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression.

Authors:  D Eick; G W Bornkamm
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

10.  Presence of a c-myc transcript initiated in intron 1 in Friend erythroleukemia cells and in other murine cell types with no evidence of c-myc gene rearrangement.

Authors:  D Ray; P Meneceur; A Tavitian; J Robert-Lezenes
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.